FEASIBILITY OF A BRIEF YOGA INTERVENTION DURING CHEMOTHERAPY FOR PERSISTENT OR RECURRENT OVARIAN CANCER

被引：6
|
作者：
Sohl, Stephanie J. [1 ]
Danhauer, Suzanne C. [1 ]
Schnur, Julie B. [2 ]
Daly, Leslie [2 ]
Suslov, Kathryn [2 ]
Montgomery, Guy H. [2 ]
机构：
[1] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC 27157 USA
[2] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA
来源：
EXPLORE-THE JOURNAL OF SCIENCE AND HEALING | 2012年 / 8卷 / 03期
关键词：
PREVALENCE; DISTRESS;
D O I：
10.1016/j.explore.2012.02.006
中图分类号：
R [医药、卫生];
学科分类号：
10 ;
摘要：
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [31] Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer
    Ghamande, S
    Lele, S
    Marchetti, D
    Baker, T
    Odunsi, K
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) : 142 - 147
  • [32] Weekly topotecan in the treatment of recurrent and persistent epithelial ovarian cancer
    Safra, Tamar
    Inbar, Moshe
    Menczer, Joseph
    Grisaro, Dan
    Glezerman, Marek
    Levy, Tally
    ANNALS OF ONCOLOGY, 2004, 15 : 136 - 136
  • [33] The use of continuous infusion topotecan in persistent and recurrent ovarian cancer
    Elkas, JC
    Holschneider, CH
    Katz, B
    Li, AJ
    Louie, R
    McGonigle, KF
    Berek, JS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) : 138 - 141
  • [34] Outcomes of third line chemotherapy for recurrent and persistent cervical cancer
    Manders, D. B.
    Purinton, S. C.
    Lea, J. S.
    Miller, D. S.
    Kehoe, S. M.
    Richardson, D. L.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 442 - 443
  • [35] Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review
    Hirte, H. W.
    Strychowskyz, J. E.
    Oliverz, T.
    Fung-Kee-Fung, M.
    Elit, L.
    Oza, A. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (06) : 1194 - 1204
  • [36] Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic
    Ayhan, Ali
    Yilmaz Baran, Safak
    Vatansever, Dogan
    Dogan Durdag, Gulsen
    Akilli, Huseyin
    Celik, Husnu
    Taskiran, Cagatay
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (06) : 883 - 887
  • [37] Neoadjuvant chemotherapy/cytoreductive surgery/intraperitoneal chemotherapy for ovarian cancer: A feasibility assessment
    Scamon, L. G.
    Richard, S. D.
    Mcbee, W. C.
    Lesnock, J. L.
    Hurt, J. D.
    O'Malley, D. M.
    Krivak, T. C.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S143 - S143
  • [38] Feasibility of tertiary and quaternary cytoreduction in recurrent epithelial ovarian cancer
    Fanfani, F.
    Fagotti, A.
    Gallotta, V.
    Margariti, P. A.
    Monterossi, G.
    Restaino, S.
    Chiantera, V.
    Shallayeva, E.
    Scambia, G.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 115 - 115
  • [39] THE THRIVE STUDY: FEASIBILITY OF AN INTERVENTION TO PREVENT WEIGHT GAIN IN BREAST CANCER SURVIVORS DURING CHEMOTHERAPY
    Mihalko, Shannon L.
    Yax, Allison
    Oliver, Sarah
    Miller, Gary
    Melin, Susan
    Avery, Tiffany
    Hopkins, Judith
    Russell, Greg
    Brubaker, Peter
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1453 - S1454
  • [40] The feasibility of carboplatin-based intraperitoneal chemotherapy in ovarian cancer
    Kim, Sang-Wun
    Paek, Jiheum
    Nam, Eun-Ji
    Kim, Sung-Hoon
    Kim, Jae-Hoon
    Kim, Young-Tae
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 152 (02) : 195 - 199
12345